It's for the non-derivative medical marijuana and what the overall increase in cost will be with these budgetary measures and, second, in terms of the model, what the government intends to raise from the excise tax on medical marijuana. I think that's valuable information for us to have prior to our witnesses, but also prior to the amendments that we'll have to consider for this budget bill.
On April 25th, 2018. See this statement in context.